About the Authors
- Gwendlyn Kollmorgen
-
Affiliation Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Birgit Bossenmaier
-
Affiliation Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Gerhard Niederfellner
-
Affiliation Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany
- Hans-Ulrich Häring
-
Affiliation Department of Internal Medicine IV, University of Tübingen, Tübingen, Germany
- Reiner Lammers
-
* E-mail: reiner.lammers@med.uni-tuebingen.de
Affiliation Department of Internal Medicine IV, University of Tübingen, Tübingen, Germany
Competing Interests
G. Kollmorgen, B. Bossenmaier, and G. Niederfellner are employees of Roche Diagnostics. Roche Diagnostics supported the study by a grant to R. Lammers. R. Lammers shares a patent on CDCP1-specific CUB-antibodies (including CUB1 used in this study) that was licensed to Roche Diagnostics. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: BB HH RL. Performed the experiments: GK GN RL. Analyzed the data: GK BB RL. Contributed reagents/materials/analysis tools: GN RL. Wrote the paper: GK BB RL.